Send the following on WhatsApp
Continue to Chat雙特異性抗體抗腫瘤前景好!BMS 取得 Agenus 專屬授權 https://geneonline.news/bms-agenus-tigit-bispecific-antibody/?variant=zh-cn
雙特異性抗體抗腫瘤前景好!BMS 取得 Agenus 專屬授權 https://geneonline.news/bms-agenus-tigit-bispecific-antibody/?variant=zh-cn